Nihal Sinha
Board Director
Nihal is a Partner at F-Prime Capital based in the London office and focuses primarily on biotech and life sciences in Europe and the US.
At F-Prime Nihal was a member of the founding team of Orchard Therapeutics and an investor in Adaptimmune, Ensoma, Charm Therapeutics and Aviado Bio.
Prior to joining F-Prime in 2013, he worked as a strategy consultant at BCG and as an academic physician at Oxford University and UCL Hospitals.
Nihal holds a MB BChir with distinction from the University of Cambridge and is a Member of the Royal College of Physicians.
